Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

CGM and Insulin Pump

Dexcom G4 Platinum CGM with Share AP Receiver Roche Accu-Chek insulin pump

DEVICE

Closed-Loop Control System

"The devices that will be used in the Closed-Loop Control System include the following components:~DiAs - a smart-phone medical platform; Dexcom Dexcom G4 Platinum connected to DiAs via Bluetooth CGM receiver; Roche Accu-Chek insulin pump connected to DiAs via wireless Bluetooth; Remote Monitoring Server connected to DiAs via 3G or local Wi-Fi network, and Zone-MPC and HMS algorithms running on DiAs (MPC and HMS)"

Trial Locations (3)

22903

University of Virginia, Charlottesville

55905

Mayo Clinic, Rochester

93111

William Sansum Diabetes Center, Santa Barbara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of California, Santa Barbara

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of Virginia

OTHER

collaborator

University of Padova

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT02463682 - Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting | Biotech Hunter | Biotech Hunter